Showing 14,921 - 14,940 results of 123,774 for search '(( 2 d decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 2.37s Refine Results
  1. 14921
  2. 14922
  3. 14923

    Expression levels of myosin heavy chain and AMPK-PGC-1α pathway in the skeletal muscles. by Shinichiro Yamada (3600374)

    Published 2016
    “…<p>The mRNA expression levels of <i>MYH1</i> (encoding MHC type IIx), <i>MYH2</i> (encoding MHC type IIa), and <i>MYH7</i> (encoding MHC type I) normalized to β2-microglobulin levels in the intercostal muscles of SBMA (<i>n</i> = 5) and ALS (<i>n</i> = 5) subjects (A–C). …”
  4. 14924

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  5. 14925

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  6. 14926

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  7. 14927
  8. 14928

    Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study by Lauren E. Mokry (787325)

    Published 2015
    “…MR analyses found that each genetically determined one-standard-deviation decrease in log-transformed 25OHD level conferred a 2.0-fold increase in the odds of MS (95% CI: 1.7–2.5; <i>p</i> = 7.7 × 10<sup>−12</sup>; <i>I</i><sup>2</sup> = 63%, 95% CI: 0%–88%). …”
  9. 14929
  10. 14930
  11. 14931

    PrioV3 and ICSM35 antibodies inhibit accumulation of PrP<sup>Sc</sup> in ScN2a cells. by Daryl Rhys Jones (351314)

    Published 2013
    “…<p>ScN2a cells were incubated for 24 hours at 37°C (5% CO<sub>2</sub>) with 1 or 25 µg PrioV3 and ICSM35. 25 µg NCS (Normal camel serum), and BRIC126-treated as well as untreated cells were also included. …”
  12. 14932

    LARP1 regulates Netrin-1 microsomal translation. by Marie-Laure Plissonnier (337713)

    Published 2016
    “…LARP1 depletion decreases the expression of Netrin-1 protein in microsomes in Huh7.5 cells. …”
  13. 14933
  14. 14934
  15. 14935
  16. 14936
  17. 14937

    Characterization of LNCaP cell growth cultured within biomimetic hydrogels in normal growth media, RPMI and 10% FBS. by Shirly Sieh (139080)

    Published 2012
    “…<p>(A) Growth curves of LNCaP cells over 7 days for 2D cultures (left) and 28 days for 3D cultures (right) in normal growth media measured by total DNA content (mean ± SE). …”
  18. 14938

    Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus by Marie-Laure Plissonnier (337713)

    Published 2016
    “…Knockdown and forced expression experiments identified the receptor uncoordinated receptor-5 (UNC5A) as an antagonist of the Netrin-1 signal, though it did not affect the death of HCV-infected cells. …”
  19. 14939
  20. 14940

    ACE conformation in lung cancer (conformational fingerprinting of ACE). by Sergei M. Danilov (7924736)

    Published 2019
    “…Data presented as a mean of at least 2–3 independent experiments in duplicates. …”